Market revenue in 2023 | USD 2,511.3 million |
Market revenue in 2030 | USD 4,227.9 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Hereditary non-cancer testing |
Fastest growing segment | Hereditary Cancer Testing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hereditary Cancer Testing, Hereditary Non-cancer Testing |
Key market players worldwide | Myriad Genetics Inc, Invitae Corp, Illumina Inc, Natera Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Quest Diagnostics Inc, CooperSurgical, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp, Sophia Genetics SA, Fulgent Genetics Inc, MedGenome, Centogene NV Ordinary Shares, The Cooper Companies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary testing market will help companies and investors design strategic landscapes.
Hereditary non-cancer testing was the largest segment with a revenue share of 84.31% in 2023. Horizon Databook has segmented the Europe hereditary testing market based on hereditary cancer testing, hereditary non-cancer testing covering the revenue growth of each sub-segment from 2018 to 2030.
Europe dominated the global hereditary testing market in terms of revenue generation in 2018. The presence of several supportive programs or projects—initiated by both public and private entities—to improve access to genetic testing in European countries results in the region’s leading share in the market.
The EuroGentest2 project, funded by European Commission, streamlines the process of genetic testing, and enhances the quality of genetic services. Council of Europe focuses on ethical & legal issues caused by application of genetic testing and protects fundamental human rights to access them.
The presence of public agency projects that promote safe and accurate genetic testing across Europe is expected to boost demand for hereditary testing. The presence of several key companies that provide hereditary testing solutions additionally contributes to the leading share of Europe.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hereditary testing market, including forecasts for subscribers. This continent databook contains high-level insights into Europe hereditary testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account